Ara
Toplam kayıt 2, listelenen: 1-2
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study
(2019)
Purpose Studies in the last decade show survival improvement with checkpoint blocker therapy in patients with metastatic malign melanoma. Our purpose was to define the efficacy of ipilimumab according to the patient's ...
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study
(2020)
Objective
To evaluate prognostic factors associated with the use of ipilimumab in patients with mucosal and uveal melanoma.
Methods
In this multicenter, retrospective study, 31 patients with uveal and mucosal ...